BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6467211)

  • 1. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM; Leav I; Kwan PW; Russell P; Merk FB
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice.
    Kyriazis AA; Kyriazis AP; McCombs WB; Peterson WD
    Cancer Res; 1984 Sep; 44(9):3997-4005. PubMed ID: 6744315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
    Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNCaP model of human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Kawinski E; Karr JP; Rosenthal H; Chu TM; Mirand EA; Murphy GP
    Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new in vivo model to study invasion and metastasis of human bladder carcinoma.
    Ahlering TE; Dubeau L; Jones PA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6660-5. PubMed ID: 3677100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a new human urinary bladder carcinoma cell line (PS-1).
    Sanford EJ; Geder L; Dagen JE; Laychock AM; Ladda R; Rohner TJ
    Invest Urol; 1978 Nov; 16(3):246-52. PubMed ID: 81814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder.
    Russell PJ; Raghavan D; Philips J; Gregory P
    Prog Clin Biol Res; 1988; 260():167-81. PubMed ID: 3362878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer xenografts: a model of tumor cell heterogeneity.
    Russell PJ; Raghavan D; Gregory P; Philips J; Wills EJ; Jelbart M; Wass J; Zbroja RA; Vincent PC
    Cancer Res; 1986 Apr; 46(4 Pt 2):2035-40. PubMed ID: 2418959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.
    Chuang CK; Liao SK
    Anticancer Res; 2000; 20(2A):749-60. PubMed ID: 10810350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines].
    Sumi S; Kihara K; Kageyama Y; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1990 Aug; 36(8):903-6; Discussion 906-7. PubMed ID: 1700590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of epithelial cell line TBC-27 from a human bladder transitional cell carcinoma and its biological characteristics].
    Liu CJ; Ma TX; Wang ZQ; Chang JW; Liu XB; Sui ZF; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):427-9, 21. PubMed ID: 3452540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenografts of human bladder cancer in immune-deprived mice.
    Kovnat A; Armitage M; Tannock I
    Cancer Res; 1982 Sep; 42(9):3696-703. PubMed ID: 7049361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on heterotransplantation of human malignant urogenital tumors in nude mice: establishment of the tumor line in nude mice from human primary ureteral tumor and its characteristics].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Hatano Y; Waki M; Hiraiwa S; Muramatsu T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Dec; 33(12):1943-50. PubMed ID: 3448917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on KU-1 and KU-7 cells as an in vitro model of human transitional cell carcinoma of urinary bladder].
    Tazaki H; Tachibana M
    Hum Cell; 1988 Mar; 1(1):78-83. PubMed ID: 3154018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a transitional cell carcinoma line arising from a previously irradiated tumor.
    Pontes JE; Morrison K; Pierce JM; Gibas Z; Sandberg AA
    J Urol; 1984 Sep; 132(3):606-8. PubMed ID: 6471205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.